28 results
425
SPRC
SciSparc Ltd
12 Apr 24
Business combination disclosure
9:23am
., severance component, pension savings and disability insurance) and the salary basis for such contributions, severance entitlements (including … ), their respective contribution rates for each component (e.g., severance component, pension savings and disability insurance) and the salary basis
6-K
EX-99.1
SPRC
SciSparc Ltd
11 Apr 24
Agreement and Plan of Merger
4:05pm
savings and disability insurance) and the salary basis for such contributions, severance entitlements (including whether such employee, to the extent … for each component (e.g., severance component, pension savings and disability insurance) and the salary basis for such contributions, severance entitlements
F-1
EX-10.7
SPRC
SciSparc Ltd
27 Feb 24
Registration statement (foreign)
4:15pm
32(9) of the Ordinance.
2.12. “Disability” shall mean (i) the inability of a Grantee to engage in any substantial gainful activity or to perform … ), as determined by a qualified doctor acceptable to the Company, (ii) if applicable, a “permanent and total disability” as defined in Section 22(e)(3
F-1
SPRC
SciSparc Ltd
27 Feb 24
Registration statement (foreign)
4:15pm
yearly from road traffic crashes. Between 20 and 50 million people suffer from non-fatal injuries, with many incurring a disability due to their injury … conditions responsible for living with disability is characterized by the presence of different kinds of pain. With the NNHPD license, we are able to offer
6-K
EX-10.3
4m95xpqvkichsz5uih7
4 Apr 23
SciSparc completes the sale of a 49% interest in its Subsidiary that owns Wellution for $3 million
7:07am
6-K
EX-99.3
lie8he69x u3j4alaa
30 Sep 22
SciSparc Enters Agreement to Acquire Wellution™, Top Seller of American Food Supplements and Cosmetics Brand on Amazon, for $20 million
7:27am
6-K
EX-99.1
1yc75uwbvq3hsvqqd0
6 Jan 22
Report of Foreign Private Issuer
4:02pm
6-K
EX-99.1
s5e2ymx fb
5 Jan 21
Therapix Biosciences and Cyntar Ventures Entered a Non-Binding Letter of Intent for the Distribution of TheraPEA in Canada
9:12am
424B4
s8x6 fquq
20 Nov 20
Prospectus supplement with pricing info
4:43pm
F-1/A
mwhsl
4 Nov 20
Registration statement (foreign) (amended)
2:14pm
F-1/A
mo6kixx7gcm5s1zka
20 Oct 20
Registration statement (foreign) (amended)
9:57pm
6-K
EX-99.2
cbeglu
9 Oct 20
Interim Consolidated Financial Statements
12:00am
F-1/A
ap7fcqna1iu7q6t d7r
9 Oct 20
Registration statement (foreign) (amended)
12:00am
6-K
EX-99.1
9a8d3p6s
23 Jun 20
Annual and Special General Meeting of Shareholders
9:06am